Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation (Forbes)
Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation (Forbes) https://bit.ly/40Alr05
Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation — Surbhi Sarna sold her last startup, nVision Medical, for $275 million. Now she's leaving a partner role at Y Combinator to launch Collate …
0 Response to "Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation (Forbes)"
Post a Comment
THANK YOU